天然产物研究与开发 ›› 2022, Vol. 34 ›› Issue (1): 33-41.doi: 10.16333/j.1001-6880.2022.1.005

• 研究论文 • 上一篇    下一篇

白术配伍人参前后挥发油调控慢性萎缩性胃炎大鼠AQP 3、4表达的比较研究

夏佳,杨雨,张世洋,万彦,吴姣姣,许金凤,唐飞,敖慧*   

  1. 成都中医药大学药学院,成都 611137
  • 出版日期:2022-01-28 发布日期:2022-01-28
  • 基金资助:
    国家自然科学基金青年项目(81503272);四川省中医药管理局项目(2020JC0031)

Comparative study on the regulation of volatile oil of Rhizoma Atractylodis Macrocephalae on AQP 3 and 4 in rats with chronic atrophic gastritis before and after compatibility with Ginseng Radix et Rhizoma

XIA Jia,YANG Yu,ZHANG Shi-yang,WAN Yan,WU Jiao-jiao,XU Jin-feng,TANG Fei,AO Hui*   

  1. Chengdu University of Traditional Chinese Medicine,Chengdu 611137,China
  • Online:2022-01-28 Published:2022-01-28

摘要:

为探究参术药对配伍治疗慢性萎缩性胃炎的增效机制,本文就白术配伍人参前后挥发油成分物质基础变化及对慢性萎缩性胃炎大鼠胃组织水通道蛋白3(AQP 3)、水通道蛋白4(AQP 4)的影响进行了比较研究。采用水蒸气蒸馏法提取人参白术配伍前后挥发油,以GC-MS法表征挥发油化学特征,并随机将大鼠分成空白组、模型组、白术挥发油组及配伍挥发油组,使用MNNG建立慢性萎缩性胃炎模型,给药后观察各组胃黏膜组织显微、超微结构变化以及AQP 3、AQP 4的表达。结果显示,白术配伍人参后挥发油的提取量升高,经GC-MS测定,配伍后苍术酮相对含量降低,新增少量人参挥发油成分。显微及超微观察显示,模型组大鼠胃组织黏膜折叠皱起,黏膜层和固有层腺体萎缩严重,胃小凹形态改变,上皮细胞破损,炎症细胞大面积浸润,且病理评分明显高于正常组(P<0.05);各药物组与模型组相比,均缓解或改善上述病理结果,且配伍挥发油组表现更优。免疫组化结果显示,模型组大鼠胃黏膜AQP 3、AQP 4表达明显低于空白组(P<0.05);相较模型组,各药物组对胃黏膜AQP 3、AQP 4蛋白的表达有增加趋势或明显增加,且配伍挥发油组优于白术挥发油组。上述结果表明,白术配伍人参前后挥发油对慢性萎缩性胃炎均具有治疗作用,且配伍后效果更佳。其增效机制可能与苍术酮比例的减少、人参挥发油成分的少量加入及AQP 3、AQP 4表达的上调相关。

关键词: 白术, 人参, 配伍, 水通道蛋白, 慢性萎缩性胃炎

Abstract:

To explore the synergistic mechanism of Rhizoma Atractylodis Macrocephalae (RAM) combined with Ginseng Radix et Rhizoma(GRR) in the treatment of chronic atrophic gastritis(CAG),this article comparatively studied the composition of volatile oil RAM and volatile oil after RAM combined with GRR and their effects on expressions of aquaporin(AQP) 3 and AQP 4 in gastric tissue of rats with CAG.The volatile oil of RAM and the volatile oil after RAM combined with GRR were extracted by steam distillation,and characterized by gas chromatography and mass spectrometry(GC-MS) technology.Rats were randomly divided into blank group,model group,RAM volatile oil group and compatible volatile oil group.MNNG was used to establish the CAG model.The microscopic and ultrastructural changes of the gastric mucosa and the expression of AQP 3 and AQP 4 in each group were observed after administration.The results showed that the amount of volatile oil extracted from RAM was increased when combined with GRR.According to the records of GC-MS,the relative contents of atractylone was decreased after combination,and a small amount of GRR volatile oil was added.Microscopic and ultramicroscopic observations showed that gastric mucosa of rats in the model group were folded and wrinkled,and the glands in the mucosal surface and lamina propria were atrophied seriously,resulting in the morphological changes of gastric pits and damage of epithelial cells.In addition,gastric mucosa was accompanied by extensive infiltration of inflammatory cells,so the pathological score was significantly higher than that of the normal group (P<0.05).Compared with the model group,the two administration groups improved the above pathological results,and the compatible volatile oil group performed better.The immunohistochemistry results showed that expression of AQP 3 and AQP 4 in the gastric mucosa of the model group was significantly lower than that of the blank group (P<0.05).Compared with the model group,expressions of AQP 3 and AQP 4 protein in the gastric mucosa of each drug group tended to increase or significantly increase,and the compatible volatile oil group is better than the RAM volatile oil group.The above results indicated that the volatile oil of RAM before and after combined with GRR had therapeutic effects on CAG,and the oil after combination possessed better effects.The increasing efficiency might be due to the decrease of the ratio of atractylone the addition of a small amount of GRR volatile oil and the up-regulation of AQP 3 and AQP 4 expression.

Key words: Rhizoma Atractylodis Macrocephalae, Ginseng Radix et Rhizoma, compatibility, aquaporin, chronic atrophic gastritis

中图分类号:  R285